Replies to post #758183 on NorthWest Biotherapeutics Inc (NWBO)

[martyDg]

The Company has also been in negotiations since early Q4 2024 for potential acquisition of another company with a dendritic cell related technology. The Company hopes to complete these negotiations during Q2 or Q3 2025.

- Unless we receive MHRA approval and support from a big pharma, it’s risky to move forward with these kinds of deals due to our current stock trading situation. As Femike mentioned, they could do a reverse split and secure enough funding to move forward, but this will likely reduce our shareholders' value, possibly by as much as 10% of what we’re worth now.

Acquiring a company and yet you can barely keep your own lights on.

This is to proved that the CEO is an idiot whose on a buying spree despite on what she put on her 10k on-going concerns. What a bunch of clowns. She doesn't care for the ones feeding her.

SHAME ON YOU LINDA POWERS! STEP DOWN!!!!

[exwannabe]

We should find a way to reach out to management and get clarity on the following:

One would normally expect a company to provide such information. This deal and details on the Roswell deal are things dev stage companies normally disclose in the corporate presentations.

Regardless, it sounds like a deal to buy Oncovir's Polyc-ICLC for trial use which would come with an agreement on commercial terms if things go well. I fail to see why the supposed -L + Poly trial would depend on the MAA outcome.

As far as the acquisition of another DC vaccine company, it would have to be a totally failed company for NWBO to afford it.

[RobotDroid]

You can talk to a wall and call it 'undertaken discussions'. No wonder they don't pr, this 10k looks like it was written by Les on meth. Easy to make shit up, take a negative, rename it something positive, and mumble along singing a sad song. What a crew of shitheads.